Applications in Practice Clinical Tool Kit


Needs Statement and Target Audience

This activity is designed to provide educational information related to current guidelines on screening for prostate cancer and is intended for urologists and other health care professionals who manage this disease state.

Expert Faculty Contributing to Tool Kit Development

David M. Albala, MD, FACS
Activity Medical Director
Professor of Urology
Director, Center for Minimally Invasive Urologic Surgery
Duke University Medical Center
Durham, North Carolina 		  Louis Kuritzky, MD
Assistant Professor
Department of Community Health and Family Medicine
University of Florida
Gainesville, Florida 		  Michael J. Naslund, MD
Professor and Chief of Urology
Director, Maryland Prostate Cancer
University of Maryland School of Medicine
Baltimore, Maryland

Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Discuss the rationale and appropriate use of clinical guidelines in screening for prostate cancer.
  2. Describe individualized patient risk factors for prostate cancer and how to incorporate this information into an overall assessment and counseling strategy with patients.
  3. Recognize the differences, strengths, and limitations of current prostate cancer screening tests.
  4. Demonstrate familiarity with current evidence assessing prostate cancer prevention strategies, including chemoprevention with pharmacologic agents.


Co-sponsored by the Duke University School of Medicine and The France Foundation


CLICK HERE TO VIEW TECHNICAL REQUIREMENTS